Boston Medical Center has sought to have patients self-identify for lung cancer screening, administering multilingual surveys while they wait for imaging appointments.
Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%.
Rad Partners "firmly" denied the allegations, which mirror a similar complaint from Aetna, contending it plans to "vigorously defend against these claims" in court.
After losing a court battle with the Fortune 500 company last year, Jeffrey C. Allard, MD, and attorneys are homing in on an attorney's faulty credentials, claiming she "poisoned" the proceedings.
Vital Imaging Diagnostic Centers recently alerted patients about the apparent cyberattack with an unauthorized party likely gaining access to private health information.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.
